Your session is about to expire
← Back to Search
Observational for Endometrial Cancer
N/A
Recruiting
Led By Gretchen E Glaser, M.D.
Research Sponsored by Mayo Clinic
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline
Awards & highlights
Study Summary
This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.
Eligible Conditions
- Endometrial Cancer
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Accuracy of artificial intelligence (AI) algorithm applied to transvaginal ultrasound (TVUS)
Trial Design
1Treatment groups
Experimental Treatment
Group I: ObservationalExperimental Treatment1 Intervention
Patients undergo a transvaginal ultrasound examination and endometrial sampling per standard of care and have their medical records reviewed on study.
Find a Location
Who is running the clinical trial?
Mayo ClinicLead Sponsor
3,221 Previous Clinical Trials
3,767,652 Total Patients Enrolled
5 Trials studying Endometrial Cancer
4,702 Patients Enrolled for Endometrial Cancer
Gretchen E Glaser, M.D.Principal InvestigatorMayo Clinic in Rochester
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger